Clinical Trial Update: Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents [Phase 1]

View source ↗

Summary

A Phase 1 feasibility trial evaluating the ability to assess lymphoma response to precisely injected candidate chemotherapy agents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Candidate chemotherapy agents (local injection)

Snippet

Sponsor: Presage Biosciences | Conditions: Lymphoma | Phase 1 | Status: COMPLETED